Molbio Diagnostics Limited IPO

Molbio Diagnostics Limited IPO

Mainboard NSE & BSE 100% Book Built Offer
Open

Price Band

Total Issue

₹0.00 Cr

Bid Dates

TBA - TBA

Subscription

-

Est. GMP

₹0 (-)

Business Overview

Molbio is an innovative point-of-care diagnostics enterprise focused on expanding access to accurate, rapid, and cost-effective healthcare technologies for the diagnosis of infectious and non-communicable diseases. Its portable, battery-operated “Truenat” platform enables molecular diagnosis using disease-specific test kits with results available within an hour. As of Mar 31, 25, the Truenat platform supports screening and diagnosis for over 30 diseases, including tuberculosis, COVID-19, Hepatitis B and C, human immunodeficiency virus, and human papillomavirus. In addition to molecular diagnostics, the Company offers devices for radiology, digital pathology, and breast health screening. Its products are supplied globally to public health programs, diagnostic laboratories, and private and public hospitals.

Objects of Issue

  1. Funding capital expenditure to set up infrastructure for the R&D facility, Centre of Excellence, & office space.
  2. Capital expenditure for plant, machinery, & equipment for Goa Unit I, Goa Unit II, & Visakhapatnam Unit.
  3. General corporate purposes

Financial Performance

(Rs. in crores)

Financial Performance Metrics for Molbio Diagnostics IPO
Particulars Mar-25 Mar-24 Mar-23
Revenue 1,020.42 836.56 332.46
PAT 138.58 83.54 -3.45
Net Worth 952.95 807.94 706.04
Borrowings 123.16 174.58 108.44
Assets 1,461.56 1,221.06 1,034.21
NAV (₹) 84.51 71.70 62.66
EPS (₹) 12.87 9.05 -0.06

KPIs

EBITDA

24.97%

PAT

13.48%

ROE

16.20%

ROCE

20.98%

  • All the data pertains to FY 2024-25.
  • PE, PB, and market capitalization are calculated based on the Upper Price Band.

Shareholding

Promoter

46.65%

Public

53.35%

Exxora Trading LLP 41.23%
Chandrasekhar Nair 5.42%

Management

Sriram Natarajan CEO
Suhas Advant CFO

Frequently Asked Questions

What is Molbio Diagnostics IPO?
Molbio Diagnostics IPO is a Mainboard IPO having an issue size of ₹0.00 Crs. Molbio Diagnostics IPO is priced at ₹ - ₹ per share. The issue opens on 16 Apr 26 and closes on 16 Apr 26.
When will Molbio Diagnostics IPO open?
Molbio Diagnostics IPO opens on 16 Apr 26 and closes on 16 Apr 26.
What is the GMP of Molbio Diagnostics IPO?
The estimated Grey Market Premium of Molbio Diagnostics IPO is ₹0 per share (-).
What is the lot size of Molbio Diagnostics IPO?
The minimum lot size of Molbio Diagnostics IPO is 0 shares & the minimum application amount is Rs. 0.
When is the allotment of Molbio Diagnostics IPO?
The allotment date of Molbio Diagnostics IPO is 16 Apr 26.
What is the listing date of Molbio Diagnostics IPO?
The listing date of Molbio Diagnostics IPO is 16 Apr 26.
What is the subscription of Molbio Diagnostics IPO?
Molbio Diagnostics IPO is subscribed -.
What is the price band of Molbio Diagnostics IPO?
Molbio Diagnostics IPO is priced at ₹ - ₹ per share.
How to check allotment status of Molbio Diagnostics IPO?
Click the allotment link on Molbio Diagnostics IPO page of IPO360.
How to apply Molbio Diagnostics IPO in Zerodha?
  1. Go to Kite App → Tap on Bids → Tap on IPO
  2. Select the IPO → Tap on apply → Enter UPI ID
  3. Enter Qty and Price
  4. Submit the application
  5. Approve the UPI Mandate on your UPI app
How to apply Molbio Diagnostics IPO in Groww?
  1. Go to Groww App → Stocks Section → Select IPO option
  2. Select the IPO you want to apply
  3. Enter your bid details and price
  4. Enter UPI ID & submit
  5. Approve the UPI Mandate on your UPI app
How to apply Molbio Diagnostics IPO using ASBA?
  1. Log in to your bank's net banking portal.
  2. Navigate to the 'IPO' or 'ASBA' section.
  3. Select Molbio Diagnostics IPO from the list of available IPOs.
  4. Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
  5. Submit the application.
  6. Money will remain blocked till the refund date